CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTC: HMTXF) is pleased to announce the appointment of David Wood to the position of Chairman, Bryson Goodwin to the position of Chief Executive Officer, Thomas Smeenk to the position of President, and […]
Other News
Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
WEST CONSHOHOCKEN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, today announced the pricing of the previously-announced underwritten secondary offering by […]
Endonovo Therapeutics Announces Reverse Stock Split – UPDATE
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), announced today it has determined to effect a 1-for-1,000 reverse stock split of the Company’s issued common shares. The reverse stock split will take effect, and the Company’s common stock will begin […]
Resverlogix Announces Change to its Board of Directors
CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today announced that Dr. Eldon Smith has stepped down from the Board of Directors, effective today. “We would like to thank Eldon for his many years of service and wish him all the best,” […]
CathWorks FFRangio™ System Receives Regulatory Approval in Japan
KFAR-SABA, Israel and ALISO VIEJO, Calif., Dec. 11, 2019 /PRNewswire/ — CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images […]
Merit Medical launches PreludeSYNC EVO™ radial compression device in EMEA
Maastricht, The Netherlands – 11th December 2019 Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in cardiology, radiology, oncology, and endoscopy, announces the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets. The product has FDA clearance in the […]
FEops Awarded Euro 3.2 Million Grant From EU
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, has been awarded a grant of Euro 3.2 million from the European Innovation Council (EIC) accelerator programme. “We are very proud to receive this grant, given the fierce competition. This ranks us now in the top 4% of all […]
ELDORADO Selects AdaCore’s QGen for Critical Medical Applications
Model-based engineering toolsuite brings high reliability to medical device software NEW YORK & PARIS & CAMPINAS, Brazil–(BUSINESS WIRE)–AdaCore today announced that The ELDORADO Research Institute of Brazil (ELDORADO) has selected the QGen model-based code generation and verification toolsuite to support research and development of safety-critical medical device software. These applications […]
CORRECTING and REPLACING First Patient Enrolled in PROMISE II U.S. Pivotal Study of LimFlow System to Treat Chronic Limb-threatening Ischemia
Clinical Study to Evaluate Device’s Ability to Prevent Amputation and Promote Wound Healing in Patients with No Other Options CORRECTION…by LimFlow SA PARIS–(BUSINESS WIRE)–First paragraph, last sentence should read: The successful first case was performed by Mark Archie, MD, principal investigator for the PROMISE II trial at Harbor-UCLA Medical Center, […]
InspireMD Announces Planned Leadership Transition
Life sciences industry veteran Marvin Slosman appointed Chief Executive Officer Appointment adds significant medical technology commercialization experience to the InspireMD team TEL AVIV, Israel, Dec. 10, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused […]



